<< Emergency Department Management Of Calcium-Channel Blocker, Beta Blocker, And Digoxin Toxicity


symptomatic patients who have ingested a nonsustained- release calcium-channel blocker or beta blocker formulation should be observed for a period of at least 6 hours.13,136 If they remain asymptomatic, they may be discharged. Patients who become symptomatic must be treated and admitted for monitoring.

To read the rest of this section, choose one of the options below.

Already purchased this course?
Log in to read.
Purchase a subscription

Price: $449/year

140+ Credits!

Money-back Guarantee
Get Quick-Read Evidence-Based Updates
Enter your email to get free evidence-based content delivered to your inbox once per month.
Please provide a valid email address.